Immune‑mediated liver injury caused by checkpoint inhibitors: A case series and review of the literature
Maria Kyrkasiadou(National and Kapodistrian University of Athens), Amanda Psyrri(University General Hospital Attikon), Anna Boulouta(National and Kapodistrian University of Athens), Anastasios Pantazopoulos(University General Hospital Attikon), Μaria Anastasiou(National and Kapodistrian University of Athens), Konstantinos Palialexis(National and Kapodistrian University of Athens), Periklis Foukas(National and Kapodistrian University of Athens), Ioannis Kotsantis(University General Hospital Attikon), Anastasios Kyriazoglou(University General Hospital Attikon), Roubini Zakopoulou(University General Hospital Attikon), George Kavourakis(University General Hospital Attikon), Myrto Moutafi(University General Hospital Attikon), Panagiota Economopoulou(National and Kapodistrian University of Athens), Menelaos Samaras(National and Kapodistrian University of Athens), Niki Gavrielatou(National and Kapodistrian University of Athens)
Cited by 0
Related Papers
Systematic Review of Recurrent Osteosarcoma Systemic Therapy
|Cancers|2021|58
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma
|Annals of Oncology|2023|53
The DNA damage response network in the treatment of head and neck squamous cell carcinoma
|ESMO Open|2021|48
Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling
|Journal of Thoracic Oncology|2022|40